Clinical trial
Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung…
NCT00219297 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00219297 |
|---|---|
| Title | Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer |
| Official title | An Open-label, Multi-center, Phase II Study to Evaluate the Activity of Patupilone (EPO906), in the Treatment of Recurrent or Progressive Brain Metastases in Patients With Non-small Cell Lung Cancer. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Metastasis, Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Patupilone |
| Enrollment | 50 |
| Start date | Nov 16, 2005 |
| Primary completion | Jun 24, 2010 |
| Completion | Jun 24, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 21, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: